• By

    Dana Sparks

    Snake-Venom Peptide For Heart Attack Treatment

Mayo Clinic's Cardiorenal Research Laboratory is going to conduct a highly innovative research project, examining the use of Snake-Venom Peptide to treat heart attacks.   Mayo has been awarded a $2.5 million grant by The National Heart, Lung and Blood Institute (NHLBI) , for the study.  Researchers will try to determine whether the therapy could help prevent deterioration of cardiac and renal function following a heart attack, and potentially reduce further heart failure in the future in treated patients.   

Click here for entire news release
 

(read Complete

Related articles

Mayo Clinic Minute: Strategies to break the heart disease and diabetes link

Heart disease remains a leading cause of death around the world. And diabetes is one of the risk factors for heart disease. Diabetes is a growing global health concern, with [...]

By Deb Balzer • November 28, 2022
Science Saturday: Novel suppression-replacement preclinical gene therapy study shows promise in long and short QT syndromes

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome [...]

By Colette Gallagher • November 19, 2022
Heart-smart cranberry apple crisp recipe for the holidays

Cranberries have become a Thanksgiving dinner staple. How about making a heart-smart cranberry apple crisp this year?

Jen Welper, a wellness executive chef with the Mayo Clinic [...]

By Deb Balzer • November 18, 2022